磷酸化
蛋白质酪氨酸磷酸酶
磷酸酶
癌症研究
酪氨酸
体内
生物
化学
细胞生物学
生物化学
遗传学
作者
Liming Zhao,Jialiang Liu,Kangshuai Li,Chao Zhang,Tianli Chen,Zengli Liu,Yongchang Tang,Xiaoqiang Hu,Anda Shi,Lizhuang Shu,Shao Hui Huang,Shuo Lian,Minghui Zhang,Hui Li,Jin‐Peng Sun,Xiao Yu,Zhong‐Yin Zhang,Zongli Zhang,Yunfei Xu
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2023-07-27
卷期号:79 (4): 798-812
被引量:14
标识
DOI:10.1097/hep.0000000000000552
摘要
Our study identifies PTPN9 as a negative regulator of FGFR2 phosphorylation and a synergistic factor for pemigatinib treatment. The molecular mechanism, oncogenic function, and clinical significance of the PTPN9-ACAP1-FGFR2 complex are revealed, providing more evidence for CCA precision treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI